For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 (0) 400 009 774 E: firstname.lastname@example.org
Zelira Therapeutics Chairman Osagie Imasogie and Global CEO Dr Oludare Odumosu deliver a slide presentation and answer investor questions as part of a business update.
CEO Oludare Odumosu and Chairman Osagie Imasogie presentation at the Zelira AGM 2022
A Global Biopharmaceutical Company Developing and Marketing Clinically Validated Cannabinoid-Based Medicines
Start typing and press Enter to search